Development of a highly concentrated collagen ink for the creation of a 3D printed meniscus
Alfredo Ronca,
Ugo D'Amora,
Elisa Capuana,
Carla Zihlmann,
Niklaus Stiefel,
Girish Pattappa,
Ruth Schewior,
Denitsa Docheva,
Peter Angele,
Luigi Ambrosio
Affiliations
Alfredo Ronca
Institute of Polymers, Composites and Biomaterials, National Research Council, Naples, Italy
Ugo D'Amora
Institute of Polymers, Composites and Biomaterials, National Research Council, Naples, Italy; Corresponding author.
Elisa Capuana
Institute of Polymers, Composites and Biomaterials, National Research Council, Naples, Italy
Carla Zihlmann
Geistlich Pharma AG (Geistlich), Bahnhofstrasse 40, CH-6110 Wolhusen, Switzerland
Niklaus Stiefel
Geistlich Pharma AG (Geistlich), Bahnhofstrasse 40, CH-6110 Wolhusen, Switzerland
Girish Pattappa
Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany
Ruth Schewior
Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany
Denitsa Docheva
Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany; Department of Musculoskeletal Tissue Regeneration, Orthopaedic Hospital König-Ludwig-Haus, University of Wurzburg, Germany
Peter Angele
Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany; Sporthopaedicum Regensburg, Hildegard von Bingen Strasse 1, 93053 Regensburg, Germany
Luigi Ambrosio
Institute of Polymers, Composites and Biomaterials, National Research Council, Naples, Italy
The most prevalent extracellular matrix (ECM) protein in the meniscus is collagen, which controls cell activity and aids in preserving the biological and structural integrity of the ECM. To create stable and high-precision 3D printed collagen scaffolds, ink formulations must possess good printability and cytocompatibility. This study aims to overlap the limitation in the 3D printing of pure collagen, and to develop a highly concentrated collagen ink for meniscus fabrication. The extrusion test revealed that 12.5 % collagen ink had the best combination of high collagen concentration and printability. The ink was specifically designed to have load-bearing capacity upon printing and characterized with respect to rheological and extrusion properties. Following printing of structures with different infill, a series of post-processing steps, including salt stabilization, pH shifting, washing, freeze-drying, crosslinking and sterilization were performed, and optimised to maintain the stability of the engineered construct. Mechanical testing highlighted a storage modulus of 70 kPa for the lower porous structure while swelling properties showed swelling ratio between 9 and 11 after 15 min of soaking. Moreover, human avascular and vascular meniscus cells cultured on the scaffolds deposited a meniscus-like matrix containing collagen I, II and glycosaminoglycans after 28 days of culture. Finally, as proof-of-concept, human size 3D printed meniscus scaffold were created.